Strattera
NDC 16590-337
Product Information
Strattera is a NDA-approved product labeled by Stat Rx Usa Llc. Atomoxetine is used to treat attention-deficit hyperactivity disorder (ADHD) as part of a total treatment plan, including psychological, social, and other treatments. It is supplied as a brown product. This product entry covers the primary NDC 16590-337 and 3 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
WHITE (C48325 - OPAQUE WHITE)
LILLY;3250;80;MG
Code Structure Chart
Product Details
What is NDC 16590-337?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- ATOMOXETINE HYDROCHLORIDE (UNII: 57WVB6I2W0)
- ATOMOXETINE (UNII: ASW034S0B8) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- STARCH, CORN (UNII: O8232NY3SJ)
- DIMETHICONE (UNII: 92RU3N3Y1O)
- GELATIN (UNII: 2G86QN327L)
- SODIUM LAURYL SULFATE (UNII: 368GB5141J)
- FERRIC OXIDE YELLOW (UNII: EX438O2MRT)
- FERRIC OXIDE RED (UNII: 1K09F3G675)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 349591 - atomoxetine HCl 10 MG Oral Capsule
- RxCUI: 349591 - atomoxetine 10 MG Oral Capsule
- RxCUI: 349591 - atomoxetine 10 MG (as atomoxetine hydrochloride) Oral Capsule
- RxCUI: 352317 - Strattera 10 MG Oral Capsule
- RxCUI: 352317 - atomoxetine 10 MG Oral Capsule [Strattera]
* Please review the full disclaimer at the bottom of this page.